LifeMD, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $194.1M | $154.8M | $152.5M | $119.0M | $92.9M | $37.3M | $12.5M | $8.3M |
| Cost of Revenue | $27.7M | $21.4M | $18.9M | $18.7M | $18.0M | $8.9M | $2.5M | $2.0M |
| Gross Profit | $166.3M | $133.4M | $133.6M | $100.4M | $74.9M | $28.4M | $9.9M | $6.3M |
| Gross Margin | 85.7% | 86.2% | 87.6% | 84.3% | 80.6% | 76.2% | 79.7% | 76.0% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $57.9M | $57.9M | $51.7M | $47.0M | $39.5M | $45.0M | $2.4M | $2.3M |
| Operating Income | $-7.7M | $-20.4M | $-14.5M | $-43.4M | $-54.3M | $-57.8M | $-2.9M | $-2.1M |
| Operating Margin | -4.0% | -13.2% | -9.5% | -36.5% | -58.5% | -155.0% | -23.2% | -24.7% |
| Interest Expense | $1.4M | $2.2M | $2.6M | $1.3M | $3.0M | $1.7M | $761.2K | $354.4K |
| Pretax Income | $-10.2M | $-22.6M | $-17.4M | $-44.7M | $-61.3M | $-60.4M | $-3.7M | $-2.4M |
| Income Tax Expense | $45.7K | $598.0K | $428.0K | $360.7K | $7.7K | $122.5K | $-122.5K | $-124.7K |
| Net Income | $14.4M | $-21.4M | $-20.6M | $-45.5M | $-60.9M | $-58.6M | $-3.1M | $-1.2M |
| Net Margin | 7.4% | -13.8% | -13.5% | -38.3% | -65.6% | -157.3% | -25.2% | -14.9% |
| EPS (Basic) | $0.25 | $-0.60 | $-0.70 | $-1.57 | $-2.29 | $-4.44 | $-0.32 | $-0.05 |
| EPS (Diluted) | $0.25 | $-0.60 | $-0.70 | $-1.57 | $-2.29 | $-4.44 | $-0.32 | $-0.05 |
| Shares Outstanding (Basic) | 45.1M | 41.2M | 33.9M | 31.0M | 27.0M | 14.3M | 9.9M | 44.2M |
| Shares Outstanding (Diluted) | 45.1M | 41.2M | 33.9M | 31.0M | 27.0M | 14.3M | 9.9M | 44.2M |
| Dividends Per Share | — | — | — | — | — | — | — | — |